Rowitch Lab
The Rowitch Laboratory investigates the genetic mechanisms that determine glial cell identity and diversity during brain development and neurological disease. Our research has enhanced our understanding of human neonatal brain development, cerebral palsy, brain cancer, MS and leukodystrophies.
Personal Statement
As a physician-scientist, I am interested in how insights from basic neuroscience can help us better understand and find new treatments for human neurological diseases. Our research bridges the genetics of glial diversity, single-cell biology, and neonatal and clinical neuroscience.
David Rowitch, MD, PhD
Breakthrough Research
- Understanding human brain development.
- Understanding remyelination failure, neurodegeneration and progression in multiple sclerosis (MS).
- Functionally distinct glial subtypes derive from diverse embryonic origins.
- Defining pathophysiology of neonatal white matter injury and WNT signaling in cerebral palsy.
- Clinical trial with neural stem cells for rare neurogenetic disease.
Funded Research
Learn about the funding sources for our leading research programs.
Publications
Learn more about the recent research publications from the Rowitch Lab.
Laboratory Team
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Rowitch Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Job Opportunities
We are actively recruiting students and postdocs to be our colleagues and expand lab knowledge and expertise to make important breakthroughs.
Collaborations
The Rowitch Lab collaborates with a wide range of investigators within Cedars-Sinai and in institutions around the world.
- Arturo Alvarez-Buylla
- Catherine Aiken
- Gabriel Balmas
- Sam Behjati
- Steve Fancy
- Arnold Kriegstein
- Brian Popko
- Danny Reich
- Hemmen Sabir
- Dori Schafer